User contributions for Kosar Doraghi
Jump to navigation
Jump to search
27 April 2024
- 00:4900:49, 27 April 2024 diff hist +2,903 Chronic obstructive pulmonary disease history and symptoms No edit summary current
24 April 2024
- 23:1723:17, 24 April 2024 diff hist +5,051 Endocarditis overview No edit summary current
- 23:0423:04, 24 April 2024 diff hist 0 N File:IMG 1177.jpeg No edit summary current
- 22:5922:59, 24 April 2024 diff hist 0 N File:IMG 1176.jpeg No edit summary current
21 April 2024
- 04:0304:03, 21 April 2024 diff hist +198 BRENZAVVY- bexagliflozin No edit summary current
- 03:4803:48, 21 April 2024 diff hist 0 N File:IMG 1052.jpeg No edit summary current
- 03:4703:47, 21 April 2024 diff hist +12,083 N BRENZAVVY- bexagliflozin Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D. [mailto:k.doraghi@yahoo.com] |genericName=BRENZAVVY- bexagliflozin |aOrAn=a |drugClass=sodium-glucose co-transporter 2 (SGLT2) inhibitor |indicationType=treatment |indication=glycemic control in adults with type 2 diabetes mellitus |hasBlackBoxWarning=Yes |adverseReactions=female genital mycotic infections, urinary tract infection and increased urination |blackBoxWarningTitle=Warnings |blackBoxWarningBody=*Not re..."
- 03:4303:43, 21 April 2024 diff hist 0 N File:IMG 1050.jpeg No edit summary current
- 03:4003:40, 21 April 2024 diff hist 0 N File:IMG 1051.jpeg No edit summary current
- 03:3403:34, 21 April 2024 diff hist 0 N File:IMG 1049.jpeg No edit summary current
19 April 2024
- 20:0320:03, 19 April 2024 diff hist +129 Template:KDRG No edit summary current
- 19:5319:53, 19 April 2024 diff hist −69 Template:KDRG No edit summary
- 16:3016:30, 19 April 2024 diff hist +8,644 N Sparsentan Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi[mailto:k.doraghi@yahoo.com] |genericName=sparsentan |aOrAn=an |drugClass=endothelin and angiotensin II receptor antagonist |indicationType=treatment |indication=proteinuria(reduce) in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g |hasBlackBoxWarning=Yes |adverseReactions=Hepatotoxicity, Embryo-Fetal Tox..." current
- 16:2416:24, 19 April 2024 diff hist 0 N File:IMG 1046.jpeg No edit summary current
- 16:1416:14, 19 April 2024 diff hist 0 N File:IMG 1045.jpeg No edit summary current
- 16:1116:11, 19 April 2024 diff hist 0 N File:IMG 1047.jpeg No edit summary current
- 16:0516:05, 19 April 2024 diff hist 0 N File:IMG 1044.jpeg No edit summary current
18 April 2024
- 06:1806:18, 18 April 2024 diff hist +2,588 Endocarditis overview No edit summary
17 April 2024
- 04:2004:20, 17 April 2024 diff hist +9,001 Endocarditis overview No edit summary
10 April 2024
- 19:3119:31, 10 April 2024 diff hist +177 Endocarditis overview No edit summary
- 19:2019:20, 10 April 2024 diff hist 0 N File:IMG 1037.jpeg No edit summary current
3 April 2024
- 23:3123:31, 3 April 2024 diff hist +150 Endocarditis overview No edit summary
- 23:2823:28, 3 April 2024 diff hist 0 N File:IMG 0918.jpeg No edit summary current
- 23:2523:25, 3 April 2024 diff hist +3,293 Endocarditis overview No edit summary
21 March 2024
- 06:0106:01, 21 March 2024 diff hist +195 Ryzneuta No edit summary current
- 05:5805:58, 21 March 2024 diff hist 0 N File:IMG 0885.jpeg No edit summary current
19 March 2024
- 23:0823:08, 19 March 2024 diff hist +8 Ryzneuta No edit summary
- 23:0723:07, 19 March 2024 diff hist +10,751 N Ryzneuta Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com]] |genericName=RYZNEUTA -Efbemalenograstim alfa-vuxw |aOrAn=a |drugClass=leukocyte growth factor |indicationType=treatment |indication=and decrease the incidence of infection, as manifested by [febrile neutropenia], in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia |h..."
- 21:4421:44, 19 March 2024 diff hist +43 Nedosiran No edit summary current
5 March 2024
- 01:4701:47, 5 March 2024 diff hist +21,576 Endocarditis overview No edit summary
28 February 2024
- 02:4002:40, 28 February 2024 diff hist +23,635 N Vonoprazan fumarate Created page with "{{DrugProjectFormSinglePage |authorTag=Kosar Doraghi, M.D.[mailto:k.doraghi@yahoo.com] |genericName=vonoprazan fumarate |aOrAn=a |drugClass=potassium-competitive acid blocker |indicationType=treatment |indication=all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. *to maintain healing of all grades of erosive esophagitis and relief of heartburn associated with erosive esophagitis in adults. *in combinatio..." current
24 February 2024
- 20:4420:44, 24 February 2024 diff hist +513 Template:KDRG No edit summary
23 February 2024
- 21:3621:36, 23 February 2024 diff hist +8,159 N Nedosiran Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=nedosiran |aOrAn=an |drugClass=LDHA-directed small interfering RNA |indicationType=treatment |indication=lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, e.g., eGFR ≥ 30 mL/min/1.73 m2 |adverseReactions=injection site reactions |fdaLIADAdult=RIVFLOZA Injection 160 mg/mL is a clear, colorless-t..."
- 21:2521:25, 23 February 2024 diff hist 0 N File:IMG 0866.jpeg No edit summary current
- 21:2421:24, 23 February 2024 diff hist 0 N File:IMG 0864.jpeg No edit summary current
- 21:2121:21, 23 February 2024 diff hist 0 N File:IMG 0858.jpeg No edit summary current
- 21:2021:20, 23 February 2024 diff hist 0 N File:IMG 0861.jpeg No edit summary current
- 21:2021:20, 23 February 2024 diff hist 0 N File:IMG 0860.jpeg No edit summary current
- 21:1921:19, 23 February 2024 diff hist 0 N File:IMG 0859.jpeg No edit summary current
- 21:1721:17, 23 February 2024 diff hist 0 N File:IMG 0867.jpeg No edit summary current
- 21:1121:11, 23 February 2024 diff hist 0 N File:IMG 0857.jpeg No edit summary current
- 21:0921:09, 23 February 2024 diff hist 0 N File:IMG 0856.jpeg No edit summary current
- 21:0621:06, 23 February 2024 diff hist 0 N File:IMG 0855.jpeg No edit summary current
- 21:0521:05, 23 February 2024 diff hist 0 N File:IMG 0853.jpeg No edit summary current
- 20:5320:53, 23 February 2024 diff hist 0 N File:IMG 0852.jpeg No edit summary current
- 04:1604:16, 23 February 2024 diff hist +15,630 N Nirogacestat Created page with "{{DrugProjectFormSinglePage |authorTag={{KDRG}} |genericName=nirogacestat |aOrAn=a |drugClass=gamma secretase inhibitor |indicationType=treatment |indication=adult patients with progressing desmoid tumors who require systemic treatment |hasBlackBoxWarning=Yes |adverseReactions=diarrhea, ovarian toxicity, rash, nausea, fatigue, stomatitis, headache, abdominal pain, cough, alopecia, upper respiratory tract infection and [..." current
- 04:0504:05, 23 February 2024 diff hist 0 N File:IMG 0851.jpeg No edit summary current
- 04:0004:00, 23 February 2024 diff hist 0 N File:IMG 0848.jpeg No edit summary current
- 03:5903:59, 23 February 2024 diff hist 0 N File:IMG 0850.jpeg No edit summary current
- 03:5703:57, 23 February 2024 diff hist 0 N File:IMG 0847.jpeg No edit summary current
